Supplementary Figure 1 from Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

Autor:	Crystal L. Mackall, Howard Streicher, Jedd D. Wolchok, Rachel Bishop, Maya Lodish, Cindy Delbrook, Donna Bernstein, Carlos Rodriguez-Galindo, Leonard H. Wexler, Kristin Baird, Matthew Wright, Melinda S. Merchant
Rok vydání:	2023
Popis:	Absolute numbers of CD3+ and CD4+ HLA-DR+ activated T cells increase at day 21 and day 42 following ipilimumab infusion.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f31e88646c1faf0dadfa6c7abdd5333 https://doi.org/10.1158/1078-0432.22459578 Zobrazit plný text záznamu